Novel compounds capable of antagonizing islet amyloid polypeptide (IAPP) induced beta-cell damage and impaired glucose tolerance

• 收藏
• 分享

专利权人:

Neurimmune Holding AG

发明人:

Grimm, Jan,Heitz, Fabrice,Wirth, Fabian,Welt, Tobias

申请号：

AU2015228818

公开号：

AU2015228818A1

申请日:

2015.03.12

申请国别(地区):

AU

年份:

2016

代理人:

摘要：

Described are molecules specifically binding to human islet amyloid polypeptide (hIAPP) also known as amylin, particularly human-derived antibodies as well as fragments, derivatives and variants thereof for antagonizing islet amyloid polypeptide (IAPP) induced β-cell damage and impaired glucose tolerance which are symptoms typically associated with diabetes mellitus type 2 (T2D).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/